Biosante Pharmaceuticals shares owned by Citadel Advisors
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biosante Pharmaceuticals by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $33M | 549k | 59.66 |
| 2024-06-30 | $25M | 388k | 63.68 |
| 2024-03-31 | $9.7M | 140k | 69.13 |
| 2023-12-31 | $11M | 191k | 55.14 |
| 2023-09-30 | $3.7M | 64k | 58.06 |
| 2023-06-30 | $3.2M | 60k | 53.83 |
| 2023-03-31 | $579k | 15k | 39.72 |
| 2022-12-31 | $246k | 6.1k | 40.23 |
| 2022-06-30 | $2.4M | 80k | 29.67 |
| 2022-03-31 | $578k | 21k | 28.09 |
| 2021-12-31 | $2.3M | 50k | 46.10 |
| 2021-09-30 | $1.7M | 52k | 32.80 |
| 2021-06-30 | $1.6M | 47k | 35.06 |
| 2021-03-31 | $1.8M | 49k | 36.15 |
| 2020-12-31 | $2.0M | 68k | 29.05 |
| 2020-09-30 | $905k | 32k | 28.19 |
| 2020-03-31 | $1.0M | 26k | 40.53 |
| 2019-12-31 | $1.3M | 22k | 61.68 |
| 2019-09-30 | $1.1M | 15k | 72.86 |
| 2019-06-30 | $2.5M | 30k | 82.25 |
| 2019-03-31 | $2.6M | 37k | 70.61 |
| 2018-12-31 | $1.1M | 24k | 44.98 |
| 2018-09-30 | $1.9M | 33k | 56.96 |
| 2018-06-30 | $1.0M | 15k | 66.82 |
| 2018-03-31 | $2.6M | 45k | 58.13 |
| 2017-12-31 | $2.4M | 38k | 64.47 |
| 2017-09-30 | $1.6M | 31k | 52.59 |
| 2017-06-30 | $1.4M | 30k | 46.72 |
| 2017-03-31 | $700k | 14k | 49.41 |
| 2016-12-31 | $1.7M | 28k | 60.64 |
| 2016-09-30 | $3.5M | 54k | 66.32 |
| 2016-06-30 | $499k | 8.9k | 55.80 |
| 2015-09-30 | $1.0M | 25k | 39.53 |
| 2015-03-31 | $341k | 5.5k | 62.49 |
| 2014-12-31 | $348k | 6.2k | 56.45 |
| 2014-09-30 | $307k | 11k | 28.26 |
| 2014-06-30 | $599k | 17k | 34.47 |
| 2014-03-31 | $492k | 16k | 31.34 |